Related Experiment Video
Updated: May 29, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Efficacy of fixed combination amlodipine/valsartan in hospitalized patients with hypertensive disease]
Insights
Fixed amlodipine/valsartan combination effectively treated hypertension, achieving target blood pressure faster than traditional therapy. This combination reduced medication needs and masked treatment failures in hospitalized patients.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Context:
- Hypertension management in hospitalized patients.
- Comparison of fixed-dose combination therapy versus traditional therapy.
Purpose:
- To evaluate the efficacy and tolerability of a fixed amlodipine/valsartan combination in hypertensive patients.
- To compare the effectiveness of this combination with standard hospital formulary treatments.
Summary:
- A randomized study of 86 hypertensive patients showed the fixed amlodipine/valsartan combination achieved target blood pressure (BP) comparably to traditional therapy (93% vs. 90%).
- The combination therapy resulted in lower clinical and self-measured BP, quicker BP target achievement (5.8 vs. 9.2 days), and fewer antihypertensive drugs (2.5 vs. 3.0).
- A significantly lower rate of concealed treatment inefficacy was observed with the fixed combination (12% vs. 31%).
Impact:
- Demonstrates the appropriateness of in-hospital use of fixed amlodipine/valsartan for efficient hypertension control.
- Highlights the benefits of faster target BP achievement and reduced medication burden.
- Suggests this combination therapy diminishes concealed treatment inefficacy, improving patient outcomes.
Abstract:
Efficacy and tolerability of fixed amlodipine/valsartan combination was studied in 86 patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology. All patients had indications for antihypertensive therapy and were randomized either to fixed combination amlodipine/valsartan (n=43) or to therapy which corresponded to the hospital formulary (n=43). Correction of antihypertensive therapy was performed by treating physician at daily rounds. Self-control of blood pressure (BP) was performed by patients with the use of UA767PC apparatus. Results of BP self-control were compared with clinical measurements in order to detect concealed inefficacy of treatment. Results. Rate of achievement of target BP with fixed combination amlodipine/valsartan (93%) was comparable with that on traditional therapy (90%). But the use of fixed combination amlodipine/valsartan compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, p<0.05), lesser number of antihypertensive drugs (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, p<0.05). Conclusions. We have demonstrated appropriateness of inhospital administration of fixed amlodipine/valsartan combination as an approach allowing to achieve target BP in shorter time, with the use of fewer antihypertensive drugs, and diminishing concealed inefficacy of treatment.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Diuretics
Hypertension III: Clinical Manifestations and Diagnostic Studies